blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1951915

EP1951915 - DETECTION METHOD FOR HUMAN PAPPILOMAVIRUS (HPV) AND ITS APPLICATION IN CERVICAL CANCER [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.04.2013
Database last updated on 24.07.2024
Most recent event   Tooltip26.04.2013Application deemed to be withdrawnpublished on 29.05.2013  [2013/22]
Applicant(s)For all designated states
Neodiagnostic Labs. Inc.
3095 Skyway Ct.
Fremont CA 94539 / US
[2008/32]
Inventor(s)01 / CHENG, Shu-Ling
43000 Paseo Padre Parkway
Fremont, CA 94539 / US
 [2008/32]
Representative(s)Gates, Marie Christina Esther, et al
Tomkins & Co.
5 Dartmouth Road
Dublin 6 / IE
[N/P]
Former [2008/32]Gates, Marie Christina Esther, et al
Tomkins & Co. 5 Dartmouth Road
Dublin 6 / IE
Application number, filing date06846299.314.11.2006
[2008/32]
WO2006US60883
Priority number, dateUS20050737152P15.11.2005         Original published format: US 737152 P
US2006055936613.11.2006         Original published format: US 559366
[2008/32]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007059492
Date:24.05.2007
Language:EN
[2007/21]
Type: A2 Application without search report 
No.:EP1951915
Date:06.08.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 24.05.2007 takes the place of the publication of the European patent application.
[2008/32]
Search report(s)International search report - published on:US27.09.2007
(Supplementary) European search report - dispatched on:EP22.12.2009
ClassificationIPC:C12Q1/70
[2008/32]
CPC:
C12Q1/708 (EP,US); C07K14/005 (EP,US); C12N2710/20022 (EP,US);
C12N2710/20051 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/32]
TitleGerman:VERFAHREN ZUR ERKENNUNG DES MENSCHLICHEN PAPPILOMA-VIRUS UND SEINE ANWENDUNG BEI GEBÄRMUTTERHALSKREBS[2008/32]
English:DETECTION METHOD FOR HUMAN PAPPILOMAVIRUS (HPV) AND ITS APPLICATION IN CERVICAL CANCER[2008/32]
French:PROCEDE DE DETECTION DU PAPILOMAVIRUS HUMAIN (HPV) ET APPLICATION DUDIT PROCEDE AU CANCER CERVICAL[2008/32]
Entry into regional phase06.06.2008National basic fee paid 
06.06.2008Search fee paid 
06.06.2008Designation fee(s) paid 
06.06.2008Examination fee paid 
Examination procedure06.06.2008Amendment by applicant (claims and/or description)
06.06.2008Examination requested  [2008/32]
07.04.2010Despatch of a communication from the examining division (Time limit: M04)
06.08.2010Reply to a communication from the examining division
12.10.2011Despatch of a communication from the examining division (Time limit: M06)
04.04.2012Reply to a communication from the examining division
09.05.2012Despatch of a communication from the examining division (Time limit: M06)
20.11.2012Application deemed to be withdrawn, date of legal effect  [2013/22]
04.01.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/22]
Divisional application(s)EP12164498.3  / EP2522756
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.04.2010
Fees paidRenewal fee
17.11.2008Renewal fee patent year 03
12.11.2009Renewal fee patent year 04
23.11.2010Renewal fee patent year 05
15.11.2011Renewal fee patent year 06
24.10.2012Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US2004202996  (WILLIAMS INNA R [US], et al) [A] 1 * abstract *;
 [X]  - JENISON S A ET AL, "EVIDENCE OF PREVALENT GENITAL-TYPE HUMAN PAPILLOMAVIRUS INFECTIONS IN ADULTS AND CHILDREN", JOURNAL OF INFECTIOUS DISEASES, (1990), vol. 162, no. 1, ISSN 0022-1899, pages 60 - 69, XP009125452 [X] 1,3-6,8-10 * page 62, column L; table 3 * * page 62, column R, paragraph L - page 63, column L, paragraph 1 *
 [X]  - GHOSH ANNA K ET AL, "Serological responses to HPV 16 in cervical dysplasia and neoplasia: Correlation of antibodies to E6 with cervical cancer", INTERNATIONAL JOURNAL OF CANCER, (1993), vol. 53, no. 4, ISSN 0020-7136, pages 591 - 596, XP002554405 [X] 1-10 * page 594, column L, line 5 * * page 591, column R, paragraph L *

DOI:   http://dx.doi.org/10.1002/ijc.2910530411
 [X]  - KOECHEL H G ET AL, "OCCURRENCE OF ANTIBODIES TO L1 L2 E4 AND E7 GENE PRODUCTS OF HUMAN PAPILLOMAVIRUS TYPES 6B 16 AND 18 AMONG CERVICAL CANCER PATIENTS AND CONTROLS", INTERNATIONAL JOURNAL OF CANCER, (1991), vol. 48, no. 5, ISSN 0020-7136, pages 682 - 688, XP002554406 [X] 1-5 * page 682, column R, paragraph L; table 3 *

DOI:   http://dx.doi.org/10.1002/ijc.2910480509
 [PX]  - DI BONITO PAOLA ET AL, "Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins", INFECTIOUS AGENTS AND CANCER, BIOMED CENTRAL LTD, LO, (20061108), vol. 1, no. 1, ISSN 1750-9378, page 6, XP021026322 [PX] 1 * abstract *

DOI:   http://dx.doi.org/10.1186/1750-9378-1-6
International search[Y]US6933123  (HU YAO XIONG [US], et al);
 [Y]US6013262  (FRAZER IAN [AU], et al);
 [Y]US5876723  (COLE STEWART [FR], et al)
Examination   - ROCHA-ZAVALETA L ET AL, "Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia", BRITISH JOURNAL OF CANCER, (1997), vol. 75, no. 8, ISSN 0007-0920, pages 1144 - 1150
    - MESCHEDE W ET AL, "ANTIBODIES AGAINST EARLY PROTEINS OF HUMAN PAPILLOMAVIRUSES AS DIAGNOSTIC MARKERS FOR INVASIVE CERVICAL CANCER", JOURNAL OF CLINICAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, (19980201), vol. 36, no. 2, ISSN 0095-1137, pages 475 - 480, XP000749188
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.